Stay updated on TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial
Sign up to get notified when there's something new on the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page.
Latest updates to the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.3%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2.SummaryDifference0.3%
- Check32 days agoChange DetectedNew content was added on August 6, 2024, following the deletion of previous content on July 18, 2024.SummaryDifference0.7%
- Check46 days agoChange DetectedThe website has added new functionality for viewing and comparing study record versions in the latest update (v2.10.0), replacing the previous version (v2.9.7).SummaryDifference6%
- Check51 days agoChange DetectedThe study on TAK-330 to reverse the effects of Factor Xa inhibitors for adults needing urgent surgery has been updated with a new date of July 18, 2024, replacing the previous study on TAK-330 for reversal of direct oral Factor Xa inhibitor-induced anticoagulation on June 7, 2024.SummaryDifference4%
- Check54 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.3%
Stay in the know with updates to TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page.